# Boiron Inc. – FDA Inspection, Jun 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/boiron-inc/ae45dc26-27c6-46bd-afac-9e2480c2c93f
Source feed: FDA_Inspections

> FDA inspection 1324326 of Boiron Inc., June 26, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1324326
- Company Name: Boiron Inc.
- Inspection Date: 2026-06-26
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1155509 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/boiron-inc/2188dede-62b5-4eb4-9df0-73f9607ca7a0)
- FDA Inspection 1007059 - 2017-02-14
- FDA Inspection 716890 - 2011-03-18

## Related Officers

- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)
- [FDA Associated Person](https://www.keypedia.com/people/christina-k-theodorou/3c18d958-14de-4f25-9fbd-7358205155f7)
- [Rahi D. Patel](https://www.keypedia.com/people/rahi-d-patel/aa11c863-2b54-4b1d-afe4-fd8fa715faee)

Company: https://www.keypedia.com/companies/boiron-inc/502403cd-f15f-4cf9-8bc2-70e99a8749b4

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
